Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) Net Margin (2017 - 2025)

Inspire Medical Systems' Net Margin history spans 9 years, with the latest figure at 50.58% for Q4 2025.

  • For Q4 2025, Net Margin rose 3590.0% year-over-year to 50.58%; the TTM value through Dec 2025 reached 15.95%, up 928.0%, while the annual FY2025 figure was 15.95%, 928.0% up from the prior year.
  • Net Margin for Q4 2025 was 50.58% at Inspire Medical Systems, up from 4.41% in the prior quarter.
  • Across five years, Net Margin topped out at 50.58% in Q4 2025 and bottomed at 40.19% in Q1 2021.
  • The 5-year median for Net Margin is 4.32% (2021), against an average of 3.9%.
  • The largest annual shift saw Net Margin soared 16480bps in 2021 before it crashed -663bps in 2025.
  • A 5-year view of Net Margin shows it stood at 3.05% in 2021, then skyrocketed by 175bps to 2.28% in 2022, then soared by 236bps to 7.68% in 2023, then surged by 91bps to 14.68% in 2024, then skyrocketed by 245bps to 50.58% in 2025.
  • Per Business Quant, the three most recent readings for INSP's Net Margin are 50.58% (Q4 2025), 4.41% (Q3 2025), and 1.63% (Q2 2025).